Deep Chakrabarti

Papers

Total Citations

H-Index

About

Deep Chakrabarti is a leading voice in urologic oncology, with a focused expertise in the contemporary management of prostate cancer. His most-cited work, a seminal 2025 review, confronts the stark reality that prostate cancer remains the most common malignancy in two-thirds of the world, with incidence and mortality projected to double within two decades. Chakrabarti’s major contribution lies in his critical synthesis of current treatment paradigms, highlighting the absence of strong environmental links to the disease and the consequent limitations of lifestyle-based prevention. By framing this epidemiological challenge, his research underscores the urgent need for improved screening, risk stratification, and therapeutic innovation. With 24 citations already, this paper serves as a foundational reference for clinicians and researchers navigating the complexities of prostate cancer care. Chakrabarti’s work is instrumental in shaping a more evidence-based, proactive approach to a global health crisis, making him a key figure in the ongoing effort to improve outcomes for millions of men worldwide.